8-Bromo-5-chloroimidazo[1,5-a]pyridine-6-carbonitrile

Catalog No.: 
ACGFTV459
CAS No.: 
2585650-35-5
Molecular Formula: 
C8H3BrClN3
Molecular Weight: 
256.49
8-Bromo-5-chloroimidazo[1,5-a]pyridine-6-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Bromo-5-chloroimidazo[1,5-a]pyridine-6-carbonitrile
IUPAC Name8-bromo-5-chloroimidazo[1,5-a]pyridine-6-carbonitrile
Molecular FormulaC8H3BrClN3
Molecular Weight256.49
SMILESN#CC1=C(Cl)N2C(C(Br)=C1)=CN=C2
InChI KeyBMVNCCIACUOWCM-UHFFFAOYSA-N
SynonymImidazo[1,5-a]pyridine-6-carbonitrile, 8-bromo-5-chloro-;8-Bromo-5-chloroimidazo[1,5-a]pyridine-6-carbonitrile
CAS No.2585650-35-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGFTV459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACGFTV459 route product structure diagram
    ACGFTV4592585650-35-5
Inquiry

2. ACGFTV459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACGFTV459 route product structure diagram
    ACGFTV4592585650-35-5
Inquiry

3. ACGFTV459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGFTV459 route product structure diagram
    ACGFTV4592585650-35-5
Inquiry

Comments (0)